Oncology Institute Q1 2024 Earnings Report $0.29 -0.02 (-5.05%) (As of 05:42 PM ET) Earnings HistoryForecast Oncology Institute EPS ResultsActual EPS-$0.22Consensus EPS -$0.12Beat/MissMissed by -$0.10One Year Ago EPS-$0.10Oncology Institute Revenue ResultsActual Revenue$94.67 millionExpected Revenue$95.17 millionBeat/MissMissed by -$500.00 thousandYoY Revenue GrowthN/AOncology Institute Announcement DetailsQuarterQ1 2024Date5/14/2024TimeAfter Market ClosesConference Call ResourcesConference CallConference Call TranscriptTOI Earnings History Is Starlink Set For The Largest IPO In History? (Ad)He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again with Tesla… which is up more than 19,500% since 2010. For perspective, that turns $100 invested into almost $20,000!Click here now for the urgent details. Oncology Institute Earnings HeadlinesFlorida Blue Launches New Oncology Care Model for myBlue Members in Partnership with Sanitas Medical Centers and The Oncology InstituteDecember 20, 2024 | nasdaq.comFlorida Blue enhances cancer care for thousands of membersDecember 18, 2024 | globenewswire.com$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being carried out by the Fed that has nothing to do with lowering or raising interest rates... but could soon have an enormous impact on your wealth.January 2, 2025 | Stansberry Research (Ad)Grapevine Saves The Oncology Institute Millions On Healthcare SuppliesNovember 21, 2024 | globenewswire.comThe Oncology Institute, Inc. (NASDAQ:TOI) Q3 2024 Earnings Call TranscriptNovember 16, 2024 | msn.comOncology Institute Reports Strong Revenue Growth Amid ChallengesNovember 14, 2024 | markets.businessinsider.comSee More Oncology Institute Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Oncology Institute? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Oncology Institute and other key companies, straight to your email. Email Address About Oncology InstituteOncology Institute (NASDAQ:TOI), an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as educational seminars, support groups, and counseling services. The company also provides managing clinical trials, palliative care programs, stem cell transplants services, and other care delivery models associated with non-community-based academic and tertiary care settings; and conducts clinical trials for a range of pharmaceutical and medical device companies. It serves adult and senior cancer patients. The company has a strategic collaboration with Healthly Forge to offer cancer care services to patients in Southern California. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California.View Oncology Institute ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles S&P 500 Earnings Set to Shine: January's Critical Market TestCiena Rebounds: AI and Strong Guidance Drive Post-Earnings SurgeHistory Hints at a Rebound for Toll Brothers After EarningsAlibaba Stock: Why Earnings Make It a Buy Despite the Recent DipMercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead?Apple Earnings - When Really Good Just Isn’t Good Enough Upcoming Earnings Schlumberger (1/17/2025)Procter & Gamble (1/22/2025) Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
